Author: STAT

I don’t write about Northwest Biotherapeutics much anymore because it’s not cool to punch down….

In 1976, a mysterious viral disease swept through the isolated forest village of Yambuku in…

One-third of the clinical trials that led to new cancer drugs approved between 2008 and…

Over the past decade, more than 25 million people have ordered at-home DNA testing kits…

As measles case counts have exploded around the globe this year, public health officials doggedly…

Medicare and its beneficiaries could have saved an estimated $17.7 billion earlier this decade on…

While personalized CAR-T cancer therapies make headlines in biotech, Amgen has been betting big on…

Rapid advances in the development of medical devices in the 21st century are contributing to…

You bump your elbow, it swells and gets red, then it hurts. Your body dispatches…

Seizing on the surging popularity of at-home DNA testing kits, top academic medical institutions are…

The Food and Drug Administration on Thursday approved Roche’s cancer drug Rozlytrek for patients with…

Is anything too weighty to be explained over the internet? Can a new spin on…

The largest association of independent nuclear pharmacies in the U.S. has filed a lawsuit accusing…

This story is part of STAT’s quarterly series Something Ventured, which looks at early-stage startups….

As Sarepta Therapeutics waits for the Food and Drug Administration to announce an approval decision…

TRENTON, N.J. — U.S. regulators Wednesday approved a new tuberculosis medicine that shortens and improves…

WASHINGTON — A vaping industry group sued the U.S. government on Wednesday to delay an…

As more Americans look to Canada for cheaper medicines, a company whose website devoted to…

Novartis dismissed the top two scientists at its gene therapy division shortly after CEO Vas…

By some measures, the world has at last reached a tipping point in the decades-long…

A paramedic gurney flies through the trauma bay carrying an unconscious elderly gentleman. He is…

WOODSIDE, Calif. — There’s a house situated on a wooded hillside in this wealthy Bay…

For someone who has made a point of trying to steer Novartis (NVS) away from…

A version of this story first appeared in D.C. Diagnosis, STAT’s weekly newsletter about the…

As new ways to identify and treat people who use opioids and other drugs emerge,…

BOSTON — “All in for CF.” That pledge adorns the lobby of Vertex Pharmaceuticals, the…

Rise and shine, everyone, another busy day is on the way. Yes, it may be…

Scientists are very careful about claiming that no one else has ever done something before…

While large pharmaceutical companies have been reporting failure after expensive failure in their efforts to…

Here’s why it’s best to remove false teeth before surgery: You just might swallow them….

A 2 1/2-year-old girl who was deemed ineligible for the world’s most expensive drug will…

In a setback to Vertex Pharmaceuticals (VRTX), a Scottish agency determined the government should not…

Few adult Americans used prescription diet drugs to lose weight in recent years, mostly thanks…

A historic clinical trial has shown that two therapies made from Ebola antibodies appear to…

It’s easy to be pessimistic about the search for a breakthrough Alzheimer’s drug. Failures and…

WASHINGTON — Canadians are furious about the Trump administration’s plan to import their prescription drugs. And…

A long-time veteran of Ebola responses has raised serious concerns about the way the current…

WASHINGTON — A group of senators, including presidential hopefuls Sens. Elizabeth Warren (D-Mass.) and Bernie…

It’s a story that’s sadly too familiar to clinicians like me: A middle-aged patient at…

Happy Friday! Elizabeth Cooney here from Boston, filling in for Ed Silverman from a campus…

SILVER SPRING, Md. — The Food and Drug Administration has allowed medical devices that rely…

In the conclusion of her recently published book, “Bottle of Lies,” Katherine Eban briefly notes…

In the landlocked, sub-Saharan country of Malawi, oftentimes only land separates wells for drinking water…

WASHINGTON — Apps and tech companies often provide employers and advertisers with information about your…

Remember when Amarin (AMRN) said, a little more than one week ago, that the Food…

Why did Novartis keep its scandal to itself? Who knew what and when? And is…

It was not an executive shakeup that pummeled shares of Sarepta Therapeutics on Thursday. It…

Good morning. Elizabeth Cooney here in Boston filling in for Ed Silverman on a balmy…

Last summer, I thought it might be fun to have my DNA analyzed. Two companies,…

A version of this story first appeared in STAT Health Tech, our weekly newsletter about…